References
Rowland J (1997) Outcomes assessment: cancer-specific quality-of-life measures: beyond the research setting. American Society of Clinical Oncology (ASCO) Educational Book, 33rd Annual Meeting, May 1997
Gunnars B, Nygren P, Glimelius B, SBU-group (2001) Assessment of quality of life during chemotherapy (review). Acta Oncol 40:175–184
Jacobsen PB, Davis K, Cella D (2002) Assessing quality of life in research and clinical practice. Oncology 16(9 suppl):133–139
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Cella DF, Tulsky DS, Gray G et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579
Stewart A, Hays R, Ware J (1988) The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 26:724–735
Davis K, Cella D (2002) Assessing quality of life in Oncology clinical practice: a review of barriers and critical success factors. J Clin Outcomes Manage 9:327–332
Keibert G, Wait S, Bernhard J et al (2001) Practice and policy of measuring quality of life and health economics in cancer clinical trials: a survey among co-operative trial groups. Qual Life Res 9:1080–1973
Sloan JA, Cella D, Frost M et al (2002) Assessing clinical significance in measuring oncology patients quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 77:367–370
Guyatt GH, Osoba D, Wu AW et al (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77:371–383
Cella D, Bullinger M, Scott C et al (2002) Group versus individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clin Proc 77:384–392
Sloan JA, Aaronson N, Cappelleri JC (2002) Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc 77:479–487
Frost MH, Bonomi AE, Ferrans CE et al (2002) Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clin Proc 77:488–494
Sprangers MAG, Moinpour CM, Moynihan TJ et al (2002) Assessing meaningful change in quality of life over time: a user’s guide for clinicians. Mayo Clin Proc 77:561–571
Symonds T, Berzon R, Marquis P et al (2002) The clinical significance of quality-of-life results: practical considerations for specific audiences. Mayo Clin Proc 77:572–583
Detmar SB et al (2002) Health-related quality-of-life assessments and patient–physician communication. A randomized controlled trial. JAMA 288:3027–3034
Grassi L, Travado L, Gil F, Campos R, Lluch P, Baile W (2005) A communication intervention for training southern European oncologists to recognize psychosocial morbidity in cancer patients. I. development of the model and preliminary results on physicians’ satisfaction. J Cancer Educ 20:79–84
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Travado, L. Placing quality of life assessments on oncologists’ agenda. Support Care Cancer 14, 979–981 (2006). https://doi.org/10.1007/s00520-006-0130-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-006-0130-x